Back to Search Start Over

Improved Characterization of Complex β-Globin Gene Cluster Structural Variants Using Long-Read Sequencing.

Authors :
Rangan A
Hein MS
Jenkinson WG
Koganti T
Aleff RA
Hilker CA
Blommel JH
Porter TR
Swanson KC
Lundquist P
Nguyen PL
Shi M
He R
Viswanatha DS
Jen J
Klee EW
Kipp BR
Hoyer JD
Wieben ED
Oliveira JL
Source :
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2021 Dec; Vol. 23 (12), pp. 1732-1740.
Publication Year :
2021

Abstract

Complex insertion-deletion (indel) events in the globin genes manifest in widely variable clinical phenotypes. Many are incompletely characterized because of a historic lack of efficient methods. A more complete assessment enables improved prediction of clinical impact, which guides emerging therapeutic choices. Current methods have limited capacity for breakpoint assignment and accurate assessment of mutation extent, especially in cases containing duplications or multiple deletions and insertions. Technology, such as long-read sequencing, holds promise for significant impact in the characterization of indel events because of read lengths that span large regions, resulting in improved resolution. Four known complex β-globin gene cluster indel types were assessed using single-molecule, real-time sequencing technology and showed high correlation with previous reports, including the Caribbean locus control deletion (g.5,305,478_5,310,336del), a large β-gene duplication containing the Hb S mutation (g.4,640,335_5,290,171dup with g.5,248,232T>A, c.20A>T; variant allele fraction, 64%), and two nested variants (double deletions with intervening inversion): the Indian <superscript>G</superscript> γ( <superscript>A</superscript> γδβ) <superscript>0</superscript> -thalassemia (g.5,246,804-5,254,275del, g.5,254,276_5,269,600inv, and g.5,269,601_5,270,442del) and the Turkish/Macedonian (δβ) <superscript>0</superscript> thalassemia (g.5,235,064_5,236,652del, g.5,236,653_5,244,280inv, and g.5,244,281_5,255,766del). Our data confirm long-read sequencing as an efficient and accurate method to identify these clinically significant complex events. Limitations include high-complexity sample preparation requirements, which hinder routine use in clinical laboratories. Continued improvements in sample and data workflow processes are needed to accommodate volumes in a tertiary clinical laboratory.<br /> (Copyright © 2021 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1943-7811
Volume :
23
Issue :
12
Database :
MEDLINE
Journal :
The Journal of molecular diagnostics : JMD
Publication Type :
Academic Journal
Accession number :
34839893
Full Text :
https://doi.org/10.1016/j.jmoldx.2021.08.013